share_log

Maxim Group Initiates Coverage On Nutex Health With Buy Rating, Announces Price Target of $45

Maxim Group Initiates Coverage On Nutex Health With Buy Rating, Announces Price Target of $45

麦斯姆集团开始对Nutex Health进行买入评级,宣布目标价为45美元
Benzinga ·  09/18 08:33  · 评级/大行评级

Maxim Group analyst Anthony Vendetti initiates coverage on Nutex Health (NASDAQ:NUTX) with a Buy rating and announces Price Target of $45.

Maxim Group分析师Anthony Vendetti发起对Nutex Health(纳斯达克:NUTX)的覆盖,并给予买入评级并公布了45美元的目标价格。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发